This analysis explores ketogenesis effects on metabolic outcomes in type 2 diabetes, suggesting potential non-blood sugar benefits.
Ketogenesis did not independently predict HbA1c reduction; however, elevated ketone levels following SGLT2 inhibitor treatment were associated with favorable metabolic adaptations, suggesting potential extra-glycemic benefits.
No takes yet. Share an insight, caveat, or question.
Park et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: